Hawaiian Eye & Retina Meeting


Evaluations and CME Certificates

This year's evaluations are available HERE through February 21, 2023 (your username is your email and the password is "Hawaii"). Please email evals@HealioLive.com if you need assistance with this year’s credits or cme@VindicoMedEd.com if you need a certificate from a previous year.

Target Audience

The intended audience for this activity is comprehensive ophthalmologists.

Program Summary

Join your colleagues for a unique educational experience. You will be offered opportunities to engage faculty and peers in both large and small group settings, appealing to all learning styles and comfort levels. Over 100 presenters consisting of ophthalmology’s brightest minds will help take your skills to the next level and explain how to incorporate cutting-edge procedures and technologies into your practice. In addition to today’s hot topics, you’ll receive a comprehensive update on every aspect of your practice. Plus, extend your learning beyond the meeting room by attending nightly banyan tree sessions featuring open discussions in a relaxed, outdoor setting. Comprehensive Ophthalmologist Program attendees are also able to attend sessions of interest under the Retina Program. This program offers an unopposed schedule including: Breakfast programs, general sessions, exhibit hall breaks, lunch programs, afternoon programs, banyan tree sessions and evening programs (all included in the single registration fee).

Learning Objectives: General Sessions

Upon completion of this activity, attendees will have better knowledge of the following subject matters:

Oculoplastics & Aesthetics Session (Saturday)

  • Summarize the latest knowledge about eyelid pathology, as well as advances in the surgical and reconstructive repair of lesions and malpositions.
  • Assess new information about the management of thyroid eye disease.
  • Evaluate aesthetic procedures for eyelid blepharoplasty, as well as the use of neuromodulators and fillers, and strategies that can minimize complications.
  • Assess the role of non-surgical aesthetic enhancements in everyday clinical practice.
  • Examine functional and aesthetic oculoplastic skills that will strengthen the ability to identify and treat eyelid lesions, malpositions, ptosis, thyroid eye disease, as well as illustrate the ability to incorporate non-surgical aesthetic enhancements into an ophthalmology practice.

Medical Retina and Uveitis Session (Saturday)

  • Assess emerging therapies under investigation for neovascular age-related macular degeneration, diabetic macular edema, and other retinal disorders.
  • Examine current management options for postoperative inflammation, as well as for endophthalmitis.
  • Assess strategies that improve the differential diagnosis and management of uveitis.
  • Evaluate treatment options that can improve the management of proliferative diabetic retinopathy.

General Sessions (Sunday to Friday)

  • Assess instrumentation for cataract removal, current options and indications for intraocular lenses, and perioperative procedures that may achieve better results in patients.
  • Describe the current status of lens selection and replacement surgery using multifocal, trifocal, toric, accommodating intraocular lens implants, extended depth of focus IOLs, and refractive IOLs, as well as their impact on patient results.
  • Identify new techniques and develop strategies for the management of cataract, cataract with glaucoma, and refractive surgery complications.
  • Recognize new treatment techniques and technologies, and the benefit of preoperative decision making, to improve patient satisfaction following cataract and/or refractive surgery.
  • Examine the use of medical, surgical, and new management tools that have the potential to improve outcomes in patients with glaucoma.
  • Analyze current concepts for the management of corneal and external diseases, ocular surface disorders, ocular infection, inflammation, and pain.
  • Recognize, evaluate, and manage neuro-ophthalmologic processes.
  • Assess the latest information and science pertaining to pediatric ophthalmological disorders.
  • Describe new findings in ocular oncology and how they may improve patient care.
  • Examine the latest updates in practice management that serve to improve patient care.
  • Summarize the latest evidence pertaining to the medical management of retinal disorders and uveitis.

This continuing education activity is provided by

ACCREDITATION: In support of improving patient care, Vindico Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

CREDIT DESIGNATION: Vindico Medical Education designates this live activity for a maximum of 32.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

INTERNATIONAL NOTICE: This educational activity is designated for AMA PRA Category 1 Credit(s)™ for all US physicians. US physicians will receive a CME certificate and non-US physicians should contact their respective organizations for reciprocity of credit.

FACULTY/PLANNER DISCLOSURE POLICY: Vindico Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest will be mitigated prior to the commencement of the activity.

All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational uses of any products/devices.

NOTICE: Faculty, topics, program schedule and credit hours are subject to change. Audiotaping or videotaping is prohibited without written permission from the program director and the Office of Medical Affairs and Compliance.